Clinical trial · NCT05802485
PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT
Sponsor: Institut Paoli-Calmettes
Summary
The study consists of a 25 ml blood sample collection: * Before the start of treatment * Approximately 2 months after the start of induction chemotherapy * At the end of induction chemotherapy * Prior to local treatment (radiotherapy, surgery) * At the time of tumor progression Collection of tumor material: * During the initial diagnostic biopsy * On the operating room in case of surgery * At tumor biopsy in case of recurrence or progression (optional) As well as the completion of a questionnaire at inclusion.
Interventions
- collection of blood and tumor samples · OTHER
The study consists of the collection of a 25 ml blood sample: * Before the start of treatment * Approximately 2 months after the start of induction chemotherapy * At the end of induction chemotherapy * Prior to local treatment (radiotherapy, surgery) * At the time of tumor progression At the time of collection of tumor material: * During the initial diagnostic biopsy * On the operating room in case of surgery * During a tumor biopsy in case of recurrence or progression (optional) and a questionnaire evaluating the patient's spontaneous physical activities.
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Non-metastatic pancreatic adenocarcinoma that is not immediately resectable (borderline and locally advanced tumors according to the NCCN 2020 classification) * No previous treatment with surgery or chemotherapy * Age \> 18 years * General condition WHO 0-2 (patient whose general condition can allow medical treatment or surgery) * Therapeutic management at the Paoli-Calmettes Institute * Signature of the informed consent specific to the PANDORE-PANC study * Patient affiliated to a social security system or benefiting from such a system Exclusion Criteria: * Metastatic disease * Pancreatic tumor of a histological type other than adenocarcinoma * Other tumor under treatment or for which treatments have been completed for \< 1 year * Pregnant or breastfeeding women * Person in an emergency situation * Person of legal age under legal protection (guardianship, curatorship or safeguard of justice) or unable to give consent.
Sites (0)
- The registry lists no site contacts for this record.
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2023-04-06.